CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
MSS
Maison Solutions Inc. Class A Common Stock
There isn't enough reported data to score MSS yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MSS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Weak |
MSS's revenue, profitability, cash flow and balance sheet are all currently under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
MSS PE Valuation
MSS has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
MSS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| -- | |
| Limited | |
| High |
Analysts expect MSS's earnings and revenue to decline, though with profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the stronger earnings trend. Trailing diluted EPS is up 718% for CELH versus MSS down 871%.
MSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.33 | — |
| Q1 2026 | -$27.00 | -$23.50 |
| Q4 2025 | -$13.50 | -$5.50 |
| Q3 2025 | -$2.50 | +$4.50 |
| Q2 2025 | $3.50 | +$13.00 |
| Q1 2025 | -$3.50 | -$2.87 |
| Q4 2024 | -$8.00 | -331% |
| Q3 2024 | -$7.00 | -259% |
| Q2 2024 | -$9.50 | -390% |
MSS lost $27.00 per share over the past year, and its loss has widened in each of the last three quarters.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the stronger quarterly revenue trend. Revenue is up 17% for CELH versus down 13% for MSS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
MSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $29.5M | -13% |
| Q4 2025 | $27.6M | -11% |
| Q3 2025 | $27.2M | -8.4% |
| Q2 2025 | $29.4M | +74% |
| Q1 2025 | $34.1M | +151% |
| Q4 2024 | $31M | +125% |
| Q3 2024 | $29.6M | +116% |
| Q2 2024 | $16.9M | +19% |
MSS's revenue has held roughly level: $30M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -9.5% | -13 points |
| Q4 2025 | -4.9% | -7.1 points |
| Q3 2025 | 0.7% | -4.8 points |
| Q2 2025 | -16% | -1.6 points |
| Q1 2025 | 3.3% | +5.5 points |
| Q4 2024 | 2.2% | +0.3 points |
| Q3 2024 | 5.5% | +7.1 points |
| Q2 2024 | -14% | -14 points |
MSS's operating margin was −9.5% last quarter, down 13 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with MSS at down 160%.
MSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $1.5M | -7.8% |
| Q4 2025 | -$1.7M | -254% |
| Q3 2025 | $1.1M | -70% |
| Q2 2025 | -$1.6M | +$985.7K |
| Q4 2024 | $1.1M | +$1.2M |
| Q3 2024 | $3.6M | +501% |
| Q2 2024 | -$2.6M | -2860% |
| Q4 2023 | -$120.4K | +$1.5M |
MSS's free cash flow was −$718,223 over the past year, against $4M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over MSS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
MSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +43% | +219K shares |
| 1 year | +109% | +380K shares |
| 3 years | +92% | +349K shares |
MSS has 729,337 diluted shares, up 109% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
MSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 16.5x | High |
| Q4 2023 | -36.9x | Net Cash |
| Q3 2023 | -2.0x | Net Cash |
| Q2 2023 | 50.1x | High |
| Q1 2023 | 68.0x | High |
| Q4 2022 | 91.4x | High |
MSS's net debt is about 16 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
MSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.8 | Oversold |
| Stochastic | 5.2 | Oversold |
MSS's weekly RSI is 24 (oversold) and its Stochastic is 5 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
MSS PE vs Consumer Defensive Sector
MSS has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus MSS above 0 of 4.
MSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.30 | 25% below |
| 20 week MA | $1.69 | 42% below |
| 50 week MA | $7.23 | 86% below |
| 100 week MA | $27.5 | 96% below |
MSS is in a downtrend: it's below all four of its weekly moving averages, and 96% below its 100-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over MSS on returns for 2026, with the stronger performance.
MSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $366.0 | $68.5 | -81% |
| 2024 | $68.5 | $62.5 | -8.8% |
| 2025 | $62.5 | $17.8 | -72% |
| 2026 YTD | $17.8 | $0.98 | -94% |
MSS has finished every year since 2023 lower, and it's down 94% so far in 2026.